ORGANIC
LETTERS
2011
Vol. 13, No. 13
3490–3493
Nickel(0)-Catalyzed Cyclization of
N-Benzoylaminals for Isoindolinone
Synthesis
Danielle M. Shacklady-McAtee, Srimoyee Dasgupta, and Mary P. Watson*
Department of Chemistry and Biochemistry, University of Delaware, Newark,
Delaware 19716, United States
Received May 10, 2011
ABSTRACT
A nickel(0) catalyst effectively mediates the cyclization of N-benzoyl aminals in the presence of a stoichiometric Lewis acid. This method enables
preparation of a variety of isoindolinones with substitution on the benzoyl fragment and C-3 carbon. This reaction likely proceeds via an
R-amidoalkylnickel(II) intermediate, which then may cyclize via either an electrophilic aromatic substitution or an insertion pathway.
Efficient formation of nitrogen heterocycles from
readily available starting materials is crucial for the
synthesis of various pharmaceutical compounds, agro-
chemicals, and materials. One privileged substructure is
the isoindolinone, or phthalimidine, nucleus. Isoindoli-
nones with carbon substitution at C-3 are found in a
number of biologically active molecules and natural
products,1 including the anxiolytic pagoclone2 and
naturally occurring pestalachloride A3 (Figure 1). There
are a variety of methods for building this important
structure from 1,2-disubstituted benzenes, such as
1,2-diacylbenzenes, unsubstituted isoindolinones, and
o-halobenzoic amides.4 Isoindolinones can also be pre-
pared via CꢀH functionalization of a monosubstituted
benzene ring by directed ortho lithiation5 or transition-
metal-catalyzed carbonylations.6 More recently, palla-
dium- and rhodium-catalyzed oxidative olefinations of
benzoic amides have been developed.7 CꢀH functiona-
lization has also been accomplished via triflic acid
promoted aza-Nazarov cyclizations of N-benzoyl imi-
nium chlorides.8
(4) (a) Gabriel, S. Ber. 1885, 18, 3470. (b) Chen, M.-D.; He, M.-Z.;
Huang, L.-Q.; Ruan, Y.-P.; Huang, P.-Q. Chin. J. Chem. 2002, 20, 1149.
(c) Grigg, R.; Gai, X.; Khamnaen, T.; Rajviroongit, S.; Sridharan, V.;
Zhang, L.; Collard, S.; Keep, A. Can. J. Chem. 2005, 83, 990. (d) Khan,
M.; Reza, A. Tetrahedron 2005, 61, 11204. (e) Guo, S.; Xie, Y.; Hu, X.;
Xia, C.; Huang, H. Angew. Chem., Int. Ed. 2010, 49, 2728. (f) Campbell,
J. B.; Dedinas, R. F.; Trumbower-Walsh, S. Synlett 2010, 3008. (g) Pin,
F.; Comesse, S.; Garrigues, B.; Marchalin, S.; Daich, A. J. Org. Chem.
2007, 72, 1181. (h) Yamamoto, I.; Yanagi, S.; Mamba, A.; Gotoh, H.
J. Org. Chem. 1974, 39, 3924.
(1) (a) Kundu, N. G.; Khan, M. W.; Mukhopadhyay, R. J. Indian
Chem. Soc. 2001, 78, 671. (b) Bhandari, A.; Boros, E. E.; Cowan, D. J.;
Handlon, A. L.; Hyman, C. E.; Oplinger, J. A.; Rabinowitz, M. H.;
Turnbull, P. S. Intl. Pat. Appl. WO 03,076,440 (2003); Chem. Abstr.
2003, 139, 261291. (c) Wood, J. L.; Petsch, D. T.; Stoltz, B. M.; Hawkins,
E. M.; Elbaum, D.; Stover, D. R. Synthesis 1999, 1529. (d) Comins,
D. L.; Schilling, S.; Zhang, Y. Org. Lett. 2005, 7, 95. (e) Belliotti, T. R.;
Brink, W. A.; Kesten, S. R.; Rubin, J. R.; Wustrow, D. J.; Zoski, K. T.;
Whetzel, S. Z.; Corbin, A. E.; Pugsley, T. A.; Heffner, T. G.; Wise, L. D.
Bioorg. Med. Chem. Lett. 1998, 8, 1499. (f) Honma, T.; Hayashi, K.;
Aoyama, T.; Hashimoto, N.; Machida, T.; Fukasawa, K.; Iwama, T.;
Ikeura, C.; Ikuta, M.; Suzuki-Takahashi, I.; Iwasawa, Y.; Hayama, T.;
Nishimura, S.; Morishima, H. J. Med. Chem. 2001, 44, 4615.
(5) (a) Enders, D.; Braig, V.; Raabe, G. Can. J. Chem. 2001, 79, 1528.
(b) Oppolzer, W.; Wills, M.; Kelly, M. J.; Signer, M.; Blagg, J. Tetra-
hedron Lett. 1990, 31, 5015. (c) Campbell, J. B.; Dedinas, R. F.;
Trumbower-Walsh, S. A. J. Org. Chem. 1996, 61, 6205. (d) Epsztajn,
ꢀ
J.; Jozwiak, A.; Koluda, P.; Sadokierska, I.; Wilkowska, I. D. Tetra-
hedron 2000, 56, 4837.
(2) (a) Sorbera, L. A.; Leeson, P. A.; Silvestre, J.; Castaner, J. Drug
Future 2001, 26, 651. (b) Stuk, T. L.; Assink, B. K.; Bates, R. C., Jr.;
Erdman, D. T.; Fedij, V.; Jennings, S. M.; Lassig, J. A.; Smith, R. J.;
Smith, T. L. Org. Process Res. Dev. 2003, 7, 851.
(6) Bird, C. W. J. Organomet. Chem. 1973, 47, 281.
(7) (a) Zhu, C.; Falck, J. R. Org. Lett. 2011, 13, 1214. (b) Wang, F.;
Song, G.; Li, X. Org. Lett. 2010, 12, 5430.
(3) (a) Li, E.; Jiang, L.; Guo, L.; Zhang, H.; Che, Y. Bioorg. Med.
Chem. 2008, 16, 7894. (b) Slavov, N.; Cvengros, J.; Neudoerfl, J.-M.;
Schmalz, H.-G. Angew. Chem., Int. Ed. 2010, 49, 7588.
(8) (a) Klumpp, D. A.; Zhang, Y.; O’Connor, M. J.; Esteves, P. M.;
de Almeida, L. S. Org. Lett. 2007, 9, 3085. (b) Sai, K. K. S.; O’Connor,
M. J.; Klumpp, D. A. Tetrahedron Lett. 2010, 52, 2195.
r
10.1021/ol201248c
Published on Web 06/06/2011
2011 American Chemical Society